FDA
approval
· 2024-05-31
FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application to market a fixed-dose combination tablet of lisinopril and hydrochlorothiazide, manufactured by Exelan Pharmaceutic…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS)